Unfortunately, we don't support Internet Explorer anymore as it has been replaced by Microsoft Edge. Please try using Edge or an alternative modern browser for the best experience.
Dr. Bülent Kızıltan is an experienced AI executive with over 20 years of cross-industry expertise, specializing in advancing pharmaceutical R&D through artificial intelligence. He has led enterprise-wide AI strategies that accelerate drug discovery, enhance clinical trial efficiency, and deliver measurable business outcomes, improving both operational processes and scientific innovation.
With a track record of driving large-scale AI initiatives, Dr. Kızıltan has successfully led global organizational transformations, spearheaded significant AI investments, and established strategic partnerships with leading technology companies. His work has helped position organizations to leverage AI as a core driver of innovation and long-term business value. Dr. Kızıltan serves on advisory councils for Harvard Business Review and MIT Technology Review, providing insights into the future of AI in life sciences.
